Issue 2, 2024

An active transport dual adaptive nanocarrier designed to overcome the corneal microenvironment for neovascularization therapy

Abstract

The eyes have a complicated microenvironment with many clearance mechanisms, making it challenging for effective drug delivery to the targeted areas of the eyes. Substrate transport mediated by active transporters is an important way to change drug metabolism in the ocular microenvironment. We designed multifunctional, dual-adaptive nanomicelles (GSCQ@NTB) which could overcome multiple physiological barriers by acting on both the efflux transporter and influx transporter to achieve deep delivery of the P-gp substrate in the cornea. Specifically, an effective “triple” antiangiogenic agent, nintedanib (NTB), was loaded into the biocompatible micelles. The expression of the efflux transporter was reversed by grafting quercetin. The peptide (glycylsarcosine, GS) was modified to target the influx transporter “Peptide Transporter-1” (PepT-1). Quercetin (QRT) and nintedanib (NTB) were transported to the cornea cooperatively, achieving long retention on the ocular surface and high compatibility. In a New Zealand rabbit model, within 8 hours after local administration, GSCQ@NTB was enriched in corneal stromal neovascularization and effectively inhibited the progress of neovascularization. Its effectiveness is slightly better than that in the first-line clinical application of steroids. In this study, we introduce the preparation of a dual adaptive nano-micelle system, which may provide an effective non-invasive treatment for corneal neovascularization.

Graphical abstract: An active transport dual adaptive nanocarrier designed to overcome the corneal microenvironment for neovascularization therapy

Supplementary files

Article information

Article type
Paper
Submitted
18 Aug 2023
Accepted
02 Nov 2023
First published
10 Nov 2023

Biomater. Sci., 2024,12, 361-374

An active transport dual adaptive nanocarrier designed to overcome the corneal microenvironment for neovascularization therapy

R. Wang, Y. Li, S. Gao, Y. Zhang, Z. He, J. Ji, X. Yang, L. Ye, L. Zhao, A. Liu and G. Zhai, Biomater. Sci., 2024, 12, 361 DOI: 10.1039/D3BM01349A

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements